130 related articles for article (PubMed ID: 6715565)
1. A controlled endoscopic study comparing the toxic effects of sulindac, naproxen, aspirin, and placebo on the gastric mucosa of health volunteers.
Lanza FL; Nelson RS; Rack MF
J Clin Pharmacol; 1984; 24(2-3):89-95. PubMed ID: 6715565
[TBL] [Abstract][Full Text] [Related]
2. Gastric bleeding and gastric secretion with sulindac and naproxen.
Hunt JN; Smith JL; Jiang CL
Dig Dis Sci; 1983 Feb; 28(2):169-73. PubMed ID: 6600677
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa.
Graham DY; Smith JL; Holmes GI; Davies RO
Clin Pharmacol Ther; 1985 Jul; 38(1):65-70. PubMed ID: 3874038
[TBL] [Abstract][Full Text] [Related]
4. The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study.
Lanza FL; Royer GL; Nelson RS; Chen TT; Seckman CE; Rack MF
Dig Dis Sci; 1979 Nov; 24(11):823-8. PubMed ID: 520100
[TBL] [Abstract][Full Text] [Related]
5. Gastroscopic observations following aspirin and naproxen sodium administration.
Halvorsen L; Sevelius H
J Clin Pharmacol; 1981 Apr; 21(4):169-72. PubMed ID: 7240438
[TBL] [Abstract][Full Text] [Related]
6. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.
Lanza FL; Evans DG; Graham DY
Am J Gastroenterol; 1991 Jun; 86(6):735-7. PubMed ID: 2038996
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
8. Lithium interaction with sulindac and naproxen.
Ragheb M; Powell AL
J Clin Psychopharmacol; 1986 Jun; 6(3):150-4. PubMed ID: 3711365
[TBL] [Abstract][Full Text] [Related]
9. Effects of fenbufen, indomethacin, naproxen, and placebo on gastric mucosa of normal volunteers. A comparative endoscopic and photographic evaluation.
Lanza FL; Nelson RS; Greenberg BP
Am J Med; 1983 Oct; 75(4B):75-9. PubMed ID: 6605681
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 content in residual gastric juice reflects endoscopic damage to the gastric mucosa after naproxen sodium administration.
Sarosiek J; Marcinkiewicz M; Parolisi S; Peura DA
Am J Gastroenterol; 1996 May; 91(5):873-8. PubMed ID: 8633574
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trial.
Goldstein JL; Aisenberg J; Zakko SF; Berger MF; Dodge WE
Dig Dis Sci; 2008 Mar; 53(3):647-56. PubMed ID: 17676393
[TBL] [Abstract][Full Text] [Related]
12. Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin.
Cole AT; Brundell S; Hudson N; Hawthorne AB; Mahida YR; Hawkey CJ
Aliment Pharmacol Ther; 1992 Dec; 6(6):707-15. PubMed ID: 1486156
[TBL] [Abstract][Full Text] [Related]
13. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
[TBL] [Abstract][Full Text] [Related]
14. Alendronate and naproxen are synergistic for development of gastric ulcers.
Graham DY; Malaty HM
Arch Intern Med; 2001 Jan; 161(1):107-10. PubMed ID: 11146706
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized study of the injurious effects of aspirin and naproxen on the gastroduodenal mucosa in patients with rheumatoid arthritis.
Mehta S; Dasarathy S; Tandon RK; Mathur M; Malaviya AN
Am J Gastroenterol; 1992 Aug; 87(8):996-1000. PubMed ID: 1642224
[TBL] [Abstract][Full Text] [Related]
16. Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients.
Chalmers JP; West MJ; Wing LM; Bune AJ; Graham JR
Clin Exp Hypertens A; 1984; 6(6):1077-93. PubMed ID: 6378437
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the content of aggressive and protective components in gastric juice and endoscopic findings after naproxen sodium and acetaminophen administration.
Marcinkiewicz M; Peura DA; Sarosiek J
Am J Gastroenterol; 1996 Feb; 91(2):360-5. PubMed ID: 8607507
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production.
Laine L; Sloane R; Ferretti M; Cominelli F
Gastrointest Endosc; 1995 Nov; 42(5):428-33. PubMed ID: 8566633
[TBL] [Abstract][Full Text] [Related]
19. Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients.
Schuna AA; Vejraska BD; Hiatt JG; Kochar M; Day R; Goodfriend TL
J Clin Pharmacol; 1989 Jun; 29(6):524-8. PubMed ID: 2666452
[TBL] [Abstract][Full Text] [Related]
20. Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Endoscopic lesions, faecal blood loss, and symptoms not necessarily correlated, as observed after naproxen and oxindanac in healthy volunteers.
Aabakken L; Dybdahl JH; Eidsaunet W; Haaland A; Larsen S; Osnes M
Scand J Gastroenterol; 1989 Oct; 24(8):1007-13. PubMed ID: 2688064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
